Chargement en cours...
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer
BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have become important treatment options for non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutation. However, the detection of EGFR driver mutation is impeded by the lack of adequate tumor tissues, h...
Enregistré dans:
Publié dans: | J Thorac Dis |
---|---|
Auteurs principaux: | , , , , , , , , , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
AME Publishing Company
2019
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6588778/ https://ncbi.nlm.nih.gov/pubmed/31285870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.05.22 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|